Ketamine: Another Pandora’s Box or Viable Treatment for Pain?

In the wake of the opioid crisis, some physicians are seeking to utilize ketamine, a highly addictive drug, to treat chronic pain and depression. Ketamine is a generic name for Ketalar (ketamine hydrochloride) and belongs to a class of drugs known as dissociate anesthetics. Ketamine’s FDA label warns of the potential emergence of psychological issues with potentially dangerous drug interactions with barbiturates and narcotics. Ketamine has already proven its high potential for abuse and is well-known as a “recreational drug,” “club drug,,” and “date rape…
Continue reading...

Crisis in Construction: Increased Risk of Opioid Abuse in the Construction Industry

The Centers for Disease Control and Prevention (CDC) states that, on average, 130 Americans die every day from an opioid overdose. The construction industry, in particular, has been disproportionately impacted by the opioid epidemic. According to North America’s Building Trades Union, the overdose rate for workers in the construction industry is seven times that of the general population. But why? The work is physically intensive and the risk of suffering a work-related injury is higher than the national average in other occupations. Laborers tend to…
Continue reading...

“Medicine Chest of the World” Joins Fight Against Opioid Epidemic

New Jersey has joined the long – and growing – company of states and local municipalities in the fight against the opioid epidemic.  The New Jersey attorney general filed suit against Janssen Pharmaceuticals, alleging that the company misled consumers on how addictive the long term use of their opioid products were. The lawsuit by New Jersey represents a new frontier in the opioid epidemic as the state brings legal action against one of its biggest employers.  New Jersey has a deep relationship with the pharmaceutical…
Continue reading...